BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Editorial
Second line systemic therapies for hepatocellular carcinoma: Reasons for the failure 
Marcello Maida, Massimo Iavarone, Maurizio Raineri, Calogero Cammà, Giuseppe Cabibbo 
World J Hepatol 7(17):2053-2057. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2053
Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications 
Georgios I Tsiaoussis, Stelios F Assimakopoulos, Athanassios C Tsamandas, Christos K Triantos, Konstantinos C Thomopoulos 
World J Hepatol 7(17):2058-2068. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2058
Review
Prediction of liver cirrhosis, using diagnostic imaging tools 
Suk Keu Yeom, Chang Hee Lee, Sang Hoon Cha, Cheol Min Park 
World J Hepatol 7(17):2069-2079. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2069
Immunology of hepatocellular carcinoma 
Meenakshi Sachdeva, Yogesh K Chawla, Sunil K Arora 
World J Hepatol 7(17):2080-2090. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2080
Minireviews
Addiction specialist's role in liver transplantation procedures for alcoholic liver disease 
Geert Dom, Hendrik Peuskens 
World J Hepatol 7(17):2091-2099. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2091
Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis 
Hayato Nakagawa 
World J Hepatol 7(17):2110-2118. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2110
Evidence-Based Medicine
Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? 
Mercedes Amieva-Balmori, Scherezada María Isabel Mejia-Loza, Roberto Ramos-González, Felipe Zamarripa-Dorsey, Eli García-Ruiz, Nuria Pérez y López, Eumir I Juárez-Valdés, Adriana López-Luria, José María Remes-Troche 
World J Hepatol 7(17):2119-2126. Published online Aug 18, 2015. doi: 10.4254/wjh.v7.i17.2119